On the technical charts, the RSI of the stock stood at 35.22.
Godrej Properties wins luxury housing plot in Gurugram for ₹5,500 crore project (25-10-2024)
This acquisition marks GPL’s eleventh new project in FY25, bringing its total booking value from new projects to ₹22,950 crore, surpassing its annual business development target of ₹20,000 crore
NSE IPO hinges on Sebi approval: Ashish Kumar Chauhan (25-10-2024)
The National Stock Exchange of India Ltd., which has encountered delays in its initial public offering since its initial filing in 2016, requires approval from the Securities and Exchange Board of India to reapply, Chauhan stated in a Bloomberg Television interview on Friday.
Dixon Technologies sees 133% revenue surge, shares decline over 8% (25-10-2024)
Dixon’s net profit after tax reached ₹412 crore, reflecting a remarkable 265% growth compared to the previous year.
Shriram Properties drops after ED conducts raids (25-10-2024)
Shriram Properties dropped 4% to Rs 102.05 as the Enforcement Directorate officials are conducting search activity in the company’s office premises in Bengaluru and Chennai.
Shares dip a day after Piramal Pharma’s Q2 FY25 earnings: revenue jumps 17 per cent, profit climbs 350 per cent (25-10-2024)
Net profit after tax of Piramal Pharma soared by 350 per cent Y-o-Y to ₹23 crore, benefiting from strong operational efficiency and strategic initiatives
Shriram Finance shares drop 3.93% as Sensex falls (25-10-2024)
On the technical charts, the RSI of the stock stood at 35.75.
Larsen & Toubro wins order for ITER organisation’s nuclear fusion project in France (25-10-2024)
Larsen & Toubro (L&T) has won new order (significant) from the France-headquartered intergovernmental body – the ITER organisation for deployment of critical advanced technologies for assembly of ports & complex parts with the Vacuum Vessel at the world’s largest nuclear fusion project at Cadarache in Southern France. According to the company’s project classification, the value of the order ranges between Rs 1,000 crore to Rs 2,500 crore.
Glenmark Life drops after PAT slides 20% YoY to Rs 95 crore in Q2 (25-10-2024)
Glenmark Life Sciences slipped 9.76% to Rs 938 after the company’s standalone net profit declined 19.72% to Rs 95.32 core on 14.86% slide in revenue from operatios to Rs 506.88 crore in Q2 FY25 over Q2 FY24.